Patent · US Active

Detecting fetal chromosomal abnormalities using tandem single nucleotide polymorphisms

US10081841B2 · kind B2 · utility

0Cited by
7References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 18, 2013
Grant dateSep 25, 2018
Priority date—
Expiry dateNov 18, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/172
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention provides tandem single nucleotide polymorphisms and methods for their use, for example, in diagnosing Down Syndrome.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.